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53 Hyaluronan export by CFTR is defective in patients with
cystic ﬁbrosis and can be recovered by analogs of hyaluronan
disaccharide
T. Schulz1. 1University Hospital Mu¨nster, Mu¨nster, Germany
Objectives: CFTR, the channel which is mutated in CF patients, belongs to the sub-
group C of the ABC transporter family. We have previously shown that the closely
related MRP5 transporter exports hyaluronan to the extracellular matrix. In MRP5
knock out mice CFTR substituted MRP5. Hyaluronan consists of glucuronic acid
and N-acetyl-glucosamine disaccharide repeating units. Based on this disaccharide
we developed an activator of CFTR, named D4.
Methods: Human lung epithilia cells (HBE) and epithilia cells from CF patients
(CFBE) were loaded with ﬂuorescent labeled hyaluronan-oligosaccharides and the
export was detected. The effect of D4 on the iodide efﬂux from CFBE-cells
was measured by an iodide-selective electrode. The transmembrane resistance
was analysed in presence or absence of D4. The CFTR inhibitors GlyH-101 and
CFTR172 reduced hyaluronan export from several CFTR expressing cell lines.
Conclusion: In conclusion, CFTR transports hyaluronan across the plasma mem-
brane of epithelial cells and this transport mechanism is defective in CF patients.
On this basis we developed membrane permeable analogs of hyaluronan disaccha-
ride as new class of compounds. We found substances that activated hyaluronan
export from ﬁbroblasts. It activated the ion efﬂux by normal and defective DF508-
CFTR. It also enhanced the plasma membrane expression of the DF508-CFTR
protein and reduced the transepithelial resistance of epithelial cells. In a human
trail of a healthy person, it caused an opening of CFTR in the nasal epithelium.
Thus this compound is a corrector that recovered DF508-CFTR from intracellular
degradation and activated its export function.
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Cystic ﬁbrosis (CF) is the most common lethal autosomal recessive disease in the
Caucasian population, and is due to mutations in the cystic ﬁbrosis transmembrane
conductance regulator (CFTR) gene. To date, over 1700 mutations have been
identiﬁed in the CFTR gene. Among these mutations, the CF-causing missense
mutation G551D-CFTR (approx. 5% of cases) exhibits normal expression on the cell
surface but it is associated with severe disease due to its altered channel activation.
The aim of the present study was to identify speciﬁc interacting proteins of G551D-
CFTR. Membrane proteins from Wt-CFTR and G551D-CFTR expressing cells
were extracted and resolved by 2D-gel electrophoresis (2-DE). Mass Spectrometry
revealed that calumenin was only present in the proteins extracted from G551D-
CFTR expressing cells. Co-immunoprecipitations showed that calumenin is linked
to Wt- and to G551D-CFTR. The amount of bound calumenin was higher in G551D-
CFTR protein complex than in wt-CFTR complex. Nevertheless, its basal expression
was not modiﬁed in G551D-CFTR expressing cells when compared to Wt-CFTR.
Calumenin associated proteins were resolved by 2-DE and the spots were analyzed
by MS. The results indicated that calumenin is bound to chaperons, cytoskeleton
proteins and Grp78/Bip which is involved in the Unfolded Protein Response (UPR).
Therefore, we showed a calumenin-CFTR interaction and we suggest that calumenin
maybe involved in the G551D-CFTR maturation and trafﬁcking pathway. Finally, we
suggest that UPR may be triggered independently of the retention of G551D-CFTR
in the ER.
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In CF extremely viscous and sticky mucus is built up likely connected to impaired
release and expansion of mucins. MUC2 is present in small and large intestine,
where it is stored secretory granules of goblet cells at high [Ca2+] and low pH and
the N-terminus control this packing. The extracellular milieu of low [Ca2+] and
high pH likely make unpacking and release possible in a not yet fully understood
mechanism. The aim is to elucidate organization and structure of MUC2 when it
is packed and secreted.
The N-terminal part of MUC2 was expressed in CHO-K1 cells. The secreted
trimerized recombinant mucin was puriﬁed from culture medium by anion exchange
chromatography and density gradient centrifugation and analyzed by electron
microscopy (EM). The pH in the buffers was varied in the range from 5.2 to
8 to mimic conditions of secretory pathway and extracellular environment by
adding HAc (pH 5.2), MES (pH 6.2) or Tris (pH 7.4 and pH 8) with or without
calcium. Samples were adsorbed onto carbon coated EM grids and negative stained.
Processing of micrographs was performed using EMAN1 software.
When pH was low and or calcium present, rings were observed. With added
calcium, rings were formed at pH 6.2, 7.4 and 8. Without calcium rings were
assembled at pH 5.2 and 6.2 but vanished with increasing pH. 2D reﬁnements
of the projections showed rotational 5- and 6-folded symmetry. In the high density
fraction of MUC2 N-terminus puriﬁed by gradient density centrifugation assemblies
of laterally concatenated rings were obtained. The formations of these rings are
probably vital for proper packing and release of full length MUC2.
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Introduction and Methodology: We have demonstrated that CFTR is an in vitro
and in vivo substrate of calpain. Immunoblot analysis, performed using two different
antibodies recognizing the N and C terminal ends of the protein, revealed that the
proteolytic cleavage occurs between NBD-1 and R domains, generating two products
with a mass of 70 kD and 100 kD still associated each other on membranes. By
confocal microscopy, we have also observed that split CFTR is removed from the
plasma membranes and accumulated in endocytic vesicles.
Results: F508del-CFTR is equally sensitive to calpain digestion with the formation
of identical products. In FRT cell line overexpressing F508del-CFTR, the digested
protein represents more than 90% of the total and is conﬁned in endocytic vesicles.
An identical pattern has been identiﬁed analyzing PBMC of 12 CF patients
(F508del-CFTR homozigotes). A decreased afﬁnity of F508del-CFTR for HSP90
is responsible for the high degree of proteolysis observed in in vivo conditions.
Whereas cAMP-dependent phosphorylation of the channel does not affect its in
vitro sensitivity to calpain, in cells an increase in the cyclic nucleotide induces a
more sustained degradation of CFTR by favoring the extent of calpain activation.
Conclusion: Our observations indicate that calpain-mediated CFTR digestion,
occurring at plasma membranes, is a constitutive step in the normal turnover of
the channel which results highly accelerated in cells containing F508del-CFTR,
due to an increase in [Ca2+]i and to the decreased protection of the ion channel
protein by HSP90. We can concluded that the degree of CF severity could be related
to the extent of this proteolysis.
